Trial intelligence / Profile preview

RECOTHROM in Pediatric Burn Wound Excision

NCT00859547Phase 4Completed

Sponsor
ZymoGenetics
Start
Mar 2009
Primary completion
Jan 2010
Modality
Therapeutic Enzymes
Countries
1
01

Overview

A Phase 4 trial of thrombin alfa, sponsored by ZymoGenetics. Started Mar 2009; status: completed.

02

Drugs

thrombin alfa

Beyond the preview

Go deeper on NCT00859547.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00859547.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call